Trials / Completed
CompletedNCT02699255
Ventricular Arrhythmias After Pulmonary Vein Isolation
A Single-center Observational Study to Examine the Occurrence of Ventricular Arrhythmias After Pulmonary Vein Isolation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators study aimed to observe the occurrence of new premature ventricular complexes and other ventricular arrhythmias after pulmonary vein isolation.
Detailed description
Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with symptomatic atrial fibrillation. It is well known that this interventional therapy inevitably modulates the intracardiac autonomic nervous system. While this ablation might alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology remains unclear.
Conditions
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-01-27
- Completion
- 2017-01-27
- First posted
- 2016-03-04
- Last updated
- 2019-06-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02699255. Inclusion in this directory is not an endorsement.